Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Photys Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Photys Therapeutics

Photys Therapeutics

Series A

Photys Therapeutics: Pioneering small molecule platforms to restore protein function and fight diseases.

Founded
2021
Overview
Compare
Fundraising
Employees
Website

Photys Therapeutics was co-founded by Amit Choudhary from the Broad Institute and the Longwood Fund. The company’s core mission is to harness its proprietary bifunctional small molecules platform to control protein post-translational modifications. This technology aims to restore protein function, repair signaling pathways, and enhance endogenous disease-fighting mechanisms. Photys Therapeutics focuses on developing innovative treatments for various diseases by leveraging their advanced molecular platform.

The company boasts a scientific advisory board with notable figures such as MIT’s Angela Koehle. Photys has attracted significant attention and investment from key players in the biotech industry. Their achievements include pioneering new methods in protein modulation, which have the potential to revolutionize therapeutic approaches. Overall, Photys Therapeutics is making a substantial impact in the field of biomedicine by offering novel solutions to complex health challenges.

Photys Therapeutics - Similar Companies

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

BlueLight Therapeutics logo

BlueLight Therapeutics

bluelighttx.com

Initial Therapeutics logo

Initial Therapeutics

initialtx.com

Photonic Pharma logo

Photonic Pharma

photonicpharma.com

PAQ Therapeutics logo

PAQ Therapeutics

paqtx.com

Belharra Therapeutics logo

Belharra Therapeutics

Juvena Therapeutics logo

Juvena Therapeutics

Hyku logo

Hyku

Ampersand Biomedicines logo

Ampersand Biomedicines

ampersand.bio

Entact Bio logo

Entact Bio

entactbio.com

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Theradaptive logo

Theradaptive

theradaptive.com

Metaphore Biotechnologies logo

Metaphore Biotechnologies

metaphorebio.com

Vincere Biosciences logo

Vincere Biosciences

vincerebio.com

Photys Therapeutics - Quick Facts

Who are Photys Therapeutics' competitors?

Companies similar to Photys Therapeutics include ProFound Therapeutics, Rectify Pharmaceuticals, BlueLight Therapeutics and Initial Therapeutics.

When was Photys Therapeutics founded?

Photys Therapeutics was founded in 2021.

When was Photys Therapeutics' last funding round?

Photys Therapeutics' most recent funding round was for $75M (USD) in September 2022.

How much has Photys Therapeutics raised to-date?

As of Sep 8, 2022, Photys Therapeutics has raised a total of $75M (USD).

How many employees does Photys Therapeutics have?

Photys Therapeutics has 38 employees as of Feb 4, 2024.

Photys Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Small Molecules
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research